CN109303115A - 生酮减肥代餐奶昔 - Google Patents
生酮减肥代餐奶昔 Download PDFInfo
- Publication number
- CN109303115A CN109303115A CN201811165398.9A CN201811165398A CN109303115A CN 109303115 A CN109303115 A CN 109303115A CN 201811165398 A CN201811165398 A CN 201811165398A CN 109303115 A CN109303115 A CN 109303115A
- Authority
- CN
- China
- Prior art keywords
- kilograms
- weight
- milk
- product
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002576 ketones Chemical class 0.000 title claims abstract description 7
- 235000020166 milkshake Nutrition 0.000 title claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000019095 Sechium edule Nutrition 0.000 claims abstract description 19
- 235000008755 Lupinus mutabilis Nutrition 0.000 claims abstract description 18
- 235000013618 yogurt Nutrition 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 13
- 241000186660 Lactobacillus Species 0.000 claims abstract description 11
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 11
- 235000013336 milk Nutrition 0.000 claims abstract description 9
- 239000008267 milk Substances 0.000 claims abstract description 9
- 210000004080 milk Anatomy 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 7
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 5
- 239000006002 Pepper Substances 0.000 claims abstract description 5
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 5
- 235000017804 Piper guineense Nutrition 0.000 claims abstract description 5
- 235000008184 Piper nigrum Nutrition 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 240000005265 Lupinus mutabilis Species 0.000 claims abstract 2
- 244000203593 Piper nigrum Species 0.000 claims abstract 2
- 238000002156 mixing Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 229920001100 Polydextrose Polymers 0.000 abstract description 26
- 235000013856 polydextrose Nutrition 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000036772 blood pressure Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 5
- 230000001093 anti-cancer Effects 0.000 abstract description 4
- 230000001151 other effect Effects 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 235000013361 beverage Nutrition 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 3
- 230000035568 catharsis Effects 0.000 abstract description 2
- 235000013376 functional food Nutrition 0.000 abstract description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 50
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 30
- 239000001259 polydextrose Substances 0.000 description 25
- 229940035035 polydextrose Drugs 0.000 description 25
- 230000000694 effects Effects 0.000 description 21
- 240000007660 Sechium edule Species 0.000 description 17
- 235000019197 fats Nutrition 0.000 description 17
- 235000012000 cholesterol Nutrition 0.000 description 14
- 235000013365 dairy product Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000020255 yak milk Nutrition 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 102000004407 Lactalbumin Human genes 0.000 description 4
- 108090000942 Lactalbumin Proteins 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 206010033307 Overweight Diseases 0.000 description 3
- 241000722363 Piper Species 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000005213 imbibition Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 239000000877 Sex Attractant Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000923 atherogenic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 235000020887 ketogenic diet Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- -1 polysaccharide compounds Chemical class 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
Abstract
生酮减肥代餐奶昔属于功能固体饮品，尤以青藏高原天然无糖牦牛酸奶粉(牛奶)、中链三酸甘油、佛手瓜粉(黄椒)、约氏乳杆菌、聚葡萄糖等辅料为原料制成的功能食品。该产品具有提高免疫力、减肥、降血压、降血脂、降血糖、通便排毒、抗癌等功效，该产品的制作工艺：调配混合、搅拌、检验、包装成为正式产品。
Description
一、技术领域：本发明属功能固体饮品，尤以青藏高原天然无污染有机牦牛酸奶等原料，采取现代先进工艺加工而成的功能食品。
二、背景技术：本发明以无糖牦牛酸奶粉、中链三酸甘油、佛手瓜粉(黄椒)、约氏乳杆菌、聚葡萄糖等原料制成的功能固体饮品。该产品具有提高免疫力、减肥、降血压、降血脂、降血糖、通便排毒、抗癌等功效。目前市场上还没有同类产品，创新研发该产品可为给减肥瘦身的人群提供了一种新产品。该产品以纯天然和生物活性成分为原料制成的减肥奶昔、纯度高、吸收好、生物活性强、无任何副作用、口感纯正、服用方便、效果明显，适应于各年龄段的减肥人群服用。
三、发明内容：肥胖是一种营养代谢综合失调性疾病和低度全身慢性炎症。研究发现，肥胖病因相当复杂，不仅有明显的遗传性，还与饮食和运动密切相关。在今天肥胖已成为一个社会严重的公共卫生问题。世界卫生组织(WHO)认为，肥胖与艾滋病、吸毒、凶酒并列为世界四大社会问题，医学界称之为人类死亡率高的癌症，冠心病、糖尿病、高血压、高血脂、心脑血管疾病都与肥胖直接有关。随着我国经济的快速发展，人民生活水平的不断提高，肥胖正在成为一个关注的流行病。根据世界卫生组织的统计数学显示，全球超重人数超过10亿多，有3亿多人严重肥胖，而发展中国家的肥胖比例大幅增加。在我国根据卫生部、科技部和国家统计局公布的营养与健康状况调查结果显示，我国13亿人口中有2亿人超重，特别是儿童超重迅速增长。预计今后肥胖患病率还将会有较大幅度的增长，肥胖会给国民健康造成严重的威胁，也会给个人和社会带来沉重的经济负担。
四、原料配方：无糖牦牛酸奶粉(牛奶)20-50千克、中链三酸甘油1-10千克、佛手瓜粉(黄椒)30-70千克、约氏乳杆菌0.5-1.5千克、聚葡萄糖10-16千克、辅料为原料。
五、技术方案：
(一)、牦牛酸奶(people wantto drinkyakmilk)，酸奶是以牦牛奶为原料，经添加不同的菌种发酵剂，发酵而成的酸奶。牦牛奶是生长在天然无污染，被世人称为净土的青藏高原海拔3500米以上的一种独有的牛种牦牛所产生的牛奶。特别是在青藏高原严酷的自然环境，造就了牦牛特具有的抗寒冷、耐高温、抗强紫外线、耐缺氧、强力抗疾病生存能力。这就是藏牦牛能适应各种恶劣环境下的独特之处。营养学家研究发现，藏牦牛全身都是宝，被称为高原之宝，由于独特的自然环境，藏牦牛奶中的乳铁蛋白和免疫球蛋白，维生素和矿物质等成分含量都远远超过了普通牛奶、另外、牦牛奶含有的二十碳五烯酸和二十二碳六烯酸及共轭亚油酸，这也是大自然特别恩赐于藏族人民强健的体质和抵抗疾病的能力。牦牛奶，性平、味甘、归肺、胃经。有补虚、益肺胃、生津润肠。适用于儿童青少年、老年身体虚弱、消化不良、肠燥便秘。现代研究表明，牦牛酸奶具有促进生长发育、防治骨质疏松、增强免疫力、延缓衰老、降血压、降血糖、减肥瘦身、美容养颜、抗癌等功效。
营养成成分：牦牛酸奶含有100多种营养成分，如蛋白质、氨基酸、多种维生素、矿物质和微量元素，其中8种人体必需氨基酸比例适宜，特别适合儿童青少年生长发育，增强体质和免疫功能，减肥等作用，为低糖生酮包含。
生理功能：1、减肥：近年来多项研究表明，在摄入热量不变的前提下，饮食中增加牦牛乳制品的摄入量有助于减肥。因为牦牛乳制品含有丰富的钙和其他一些特殊的活性成分，能帮助人体燃烧脂肪，减少脂肪积累和控制体重有着重要的作用。牦牛乳制品有助于控制体重的另一个因素可能与它对食欲的控制有关。研究表明，无论在高脂肪或低脂肪膳食条件下，膳食加入牦牛乳制品都增加餐后缩胆囊肽的分泌，产生较强的饱腹感，从而控制食饮。进一步研究证实，牦牛奶中钙能帮助人体降低脂防储备的同时加速脂肪燃烧速度。牦牛乳制品能帮助减肥的另一个重要原因是乳清蛋白，乳清蛋白所包含的营养成分可刺激肌肉组织构建，而这个过程也正是燃烧脂肪的过程。另外，牦牛酸奶还具有调节肠道功能、降血脂、降血糖、降低胆固醇，增强免疫力，美容养颜，防癌抗癌等功能。
2、降血压，近年来研究数据表明，乳制品可能与控制血压相关联。分析证实乳制品的钙比非乳制品钙增补剂降压效果高1倍。研究推测，这可能是由乳制品的钾、镁和钙恰当平衡有利于降血压。乳制品的另一个降血压因素可能使降压生物活性肽。牦牛酸奶粉中的酪蛋白和乳清蛋白都是血管紧张素转换酶(ACE)抑制肽的来源，他们可以通过酶水解、胃肠道消化或食品加过程释放出来。目前，从多种奶酪乳清、酪蛋白、乳清蛋白、β-乳球蛋白等均能分离出抗高血压活性肽，在以自发性高血压大鼠为材料实验中具有降血压活性。
3、降血糖：研究表明，每天喝一些牦牛酸奶粉可降40％的几率患糖尿病。因为牛奶中的钙、镁、维生素D可以增强人体合理使用胰岛素的功能。
另据报道，美国最新研究发现，经常进食牦牛酸奶粉，其中含有一种脂肪酸可降低患2型糖尿病的风险。研究动物实验发现，动物体内存在的棕榈酸可帮助降低胰岛素抵抗性，他们对人体通过奶制品摄入反式棕榈酸进行了调查，研究了3700多名65岁以上老年人进行了跟踪调查。结果显示，与进食奶制品最少的人相比，进食全脂奶制品最多的人患2型糖尿病的几率要低63％。其作用是因为常食全脂奶制品的人血液中的反式棕榈酸的水平较高，同样可以起到降低胰岛素抵抗作用，从而有效预防糖尿病。
(二)中链三酸甘油(MCT)，是存在于牛奶和椰子油的一种脂肪酸。中链三酸甘油进入人体后在脂蛋白酶的作用下为机体提供能量和必须的脂肪酸。具有增强饱腹感、减肥、降血脂、降低胆固醇、抗疲劳和生酮作用等。
生理功能：1、生酮作用：中链三酸甘油具有比长链三酸甘油较多的生酮作用，对外围组织供能较多，有一定的节氮作用。
2、减肥：中链三酸甘油能提高人体新陈代谢率，加快燃烧热量，促进膳食中的卡路里含量消耗和能量代谢，提高机体中的糖脂代谢。减少人体脂肪的堆积和减少两餐之间饥饿，防止过量饮食。因此，中链三酸甘油具有显著的减肥效果。
(三)佛手瓜粉(sechium edule)，又名寿瓜，为葫芦科佛手瓜属成熟的果实。具有和中理气、疏肝止咳的作用。适用于消化不良、胸闷气胀、呕吐、肝胃气痛及支气管炎咳嗽等功能。现代研究表明，佛手瓜有减肥降脂、增强免疫力、降血压、扩张血管、防治心血管疾病、利尿等作用。
化学成分：佛手瓜含有蛋白质、脂肪、低糖(2.5％)、膳食纤维、多种维生素和多种矿物质及微量元素等活性成分，为低热量生酮食物。
生物学功能：1、减肥瘦身：一项新研究发现，食用佛手瓜有很好的减肥效果。新研究表明，吃高脂食物时食用佛手瓜具有降低体重的作用，这是因为佛手瓜含有的多种营养活性成分，可以抑制糖类食物转化为脂肪。另外，佛手瓜还含有丰富的膳食纤维能加快胃肠蠕动，促进大便排出，且热量也很低。因此，佛手瓜具有很好的减肥效果。
2、提高免疫力：佛手瓜含有丰富的多种营养成分，可以提高人体抗病能力和免疫细胞的再生，经常食用可提高人体免疫功能。对维持人体免疫力和提高人体抗病能力具有很好的作用。
3、降压和防治心血管疾病：佛手瓜可促进人体钠盐的排泄，而且还能促进血液循环，对高血压具有明显的降压作用。另外，佛手瓜对心血管疾病也有一定的防治作用。
4、健脾养胃和助消化：佛手瓜有理气和中的功效，还能调理脾胃，对消化不良、腹泻、恶心呕吐等症状有明显的缓解作用。
(四)、约氏乳杆菌(Lactobacillus)，约氏乳杆菌是一类能利用可发酵碳水化合物产生大量乳酸菌其中的一种。具有多种生物学活性功能。
生物学功能：1、减肥：约氏乳杆菌具有很好的减肥功效。一项新研究表明，如果在进餐时补充适量的约氏乳杆菌，对食物的消耗将大大超过机体对食物的利用，对食用的食物很少会被机体吸收，已达到减肥的效果。其作用机理为，约氏乳杆菌能阻断脂肪、胆固醇和甘油三脂在体内的合成，阻断脂肪和胆固醇的吸收，增加脂肪燃烧，调节脂肪代谢水平的能力。因此，约氏乳杆菌具有显著的减肥功效。
(五)聚葡萄糖(Polydex-tpose)，又称聚糊精，是一种高分子多糖化合物，属膳食纤维范畴。科学研究表明，聚葡萄糖具有减肥、降血脂、调节血糖、整肠通便、排毒养颜、防癌等功效。
生理功能：1、减肥：许多研究证实，聚葡萄糖有很好的减肥功效。能阻断肠黏膜对糖和淀粉的吸收，极大降低脂肪被吸收的机会，从而减少脂肪在体内合成，起到控制体重的作用。另外，聚葡萄糖还可抑制食欲，它有很强的吸水性，黏度大，膨胀率高的特点，进入胃肠吸水后膨胀，使人产生强烈的饱腹感，从而减少食物的摄入量来减少脂肪和胆固醇的吸收。因此，聚葡萄糖可以阻断外源性脂肪吸收，使得体内合成脂肪来源受阻，从而达到自然减肥的功效。另据国外报道，聚葡萄糖具有明显的减肥功效，研究人员发现，聚葡萄糖可以对人体新陈代谢以及可以调节食欲的激素产生有利影响，因此，聚葡萄糖可有效控制人的食欲，达到减轻人的体重。
2、降血脂：聚葡萄糖具有降低血清总胆固醇和甘油三酯，升高高密度脂蛋白，降低低密度脂蛋白的功能，从而防治动脉硬化指数。动物实验结果显示，聚葡萄糖能吸附胆汁酸和胃肠道胆固醇及抑制胆固醇在肠道内的吸收，促进胆固醇的转化，并将排出体外，从而使胆固醇和甘油三酯明显下降。
3、调节血糖：聚葡萄糖能改善末梢组织对胰岛素的感受性，降低胰岛素的要求，抑制胰岛素分泌，阻碍对糖的吸收，从而达到降低血糖水平的目的。而且还有防治糖尿病并发症的作用。
4、排毒养颜：聚葡萄糖属高分子水溶性多糖，能增加肠道蠕动，帮助肠道将有害毒素排出体外。研究表明，聚葡萄糖能有效调节肠道PH值，改善有益细菌繁殖环境，使双歧杆菌等有益菌群迅速增加，从而抑制腐败菌的生长，防止肠道黏膜萎缩，并及时将体内的毒素和代谢废物排出体外，避免毒素从皮肤汗腺排出，从而达到排毒养颜的作用。
5、调节肠道菌群：聚葡萄糖能促进肠道有益菌的增殖，是有效的益生元，进入人体后在胃肠上半部分不能被消化吸收，以完整的形式到达肠道被发酵，以促进肠道有益菌(双歧杆菌、乳酸杆菌)等繁殖。另外，聚葡萄糖被有益菌发酵产生的短链脂肪酸使肠道PH值下降，从而抑制肠道内一些不耐酸的病源微生物如沙门氏菌等腐败生长，改善肠道环境，减少了肠道腐败物质的产生。
6、防治便秘：聚葡萄糖为水溶性膳食纤维，能使大肠需动，有利于肠道内容物运动，增加排便次数，使粪便排出。同时聚葡萄糖还有很强的吸水性，增加大便中的含水量由此使大便变软，加速排便频率，起到润肠通便和防治便秘的作用。
7、降低胆固醇：聚葡萄糖进入肠道内后会被肠道微生物降解的产物可抑制胆固醇的合成，并能吸附胆固醇的代谢产物胆汁酸并排出体外，从而降低人体内胆固醇含量，并阻碍对胆固醇的吸收，有效防治冠状动脉硬化，胆结石和心血脑血管疾病等。
8、防癌抗癌：有动物实验显示，聚葡萄糖对小肉癌S180有明显的抑制作用，其作用机理是聚葡萄糖能有效干扰癌细胞的代谢功能，对胃和结肠癌细胞有较好的敏感性。给动物喂食10％的聚葡萄糖，可降低1.2-二甲基脂诱发肠癌的发生率。
另外，聚葡萄糖还能防龋齿和促进矿物质吸收的作用。
综上所述，本产品通过对36名女性每天服用生酮减肥营养代餐奶昔，通过6周后的检测其体内脂肪含量，结果显示，每个试验者的基础代谢率平均提高13.8％，体重平均减少3.7％，体内平均脂肪下降3.3％，腰围平均减少3.6厘米。通过上数据表明，生酮减肥营养代餐奶昔具有显著的减肥功效。
六、制作工艺：1、调配混合：将配方中的所有原料按物理特性进行混合。
2、搅拌：将混合好的原料充分搅拌均匀。
3、检验包装：将搅拌均匀的原料，检验合格包装成为正式产品。
调配混合是将配方中的原料按物理特性进行混合工序。搅拌是将混合好的原料充分搅拌均匀的工序。检验包装是将搅拌均匀的原料检验合格包装成为正式产品。
七、质量标准：
1、理化指标：
2、服用方法：每日1至3次，每次30-100克。
3、适用人群：男女老幼、儿童、青少年肥胖人群服用。
八、具体实施方式：
实施例：取无糖牦牛酸奶粉(牛奶)20-50千克、中链三酸甘油1-10千克、佛手瓜粉(黄椒)30-70千克、约氏乳杆菌0.5-1.5千克、聚葡萄糖10-16千克、辅料为原料。经过将以上原料调配混合，并充分搅拌均匀，杀菌、检验合格，包装成为正式产品。
Claims (1)
1.生酮减肥代餐奶昔的制作工艺，其组成特征为：取无糖牦牛酸奶粉(牛奶)20-50千克、中链三酸甘油1-10千克、佛手瓜粉(黄椒)30-70千克、约氏乳杆菌0.5-1.5千克、聚葡萄糖10-16千克、辅料为原料，经过将以上原料调配混合、充分搅拌均匀，检验合格，包装成为正式产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811165398.9A CN109303115A (zh) | 2018-10-08 | 2018-10-08 | 生酮减肥代餐奶昔 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811165398.9A CN109303115A (zh) | 2018-10-08 | 2018-10-08 | 生酮减肥代餐奶昔 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109303115A true CN109303115A (zh) | 2019-02-05 |
Family
ID=65225085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811165398.9A Pending CN109303115A (zh) | 2018-10-08 | 2018-10-08 | 生酮减肥代餐奶昔 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109303115A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112690334A (zh) * | 2020-12-30 | 2021-04-23 | 菌联肽康(山东)医药有限公司 | 一种代餐减肥降三高奶昔代餐系列食品及其制备工艺 |
| CN116508993A (zh) * | 2023-03-21 | 2023-08-01 | 微康益生菌(苏州)股份有限公司 | 罗伊氏乳杆菌在制备具有代谢调节作用的益生菌剂中的应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040037011A (ko) * | 2002-10-26 | 2004-05-04 | (주)바이오니아 | 유산균 함유 식품조성물 및 그 제조방법 |
| CN106912612A (zh) * | 2015-12-28 | 2017-07-04 | 中粮营养健康研究院有限公司 | 代餐奶昔粉及其制备方法 |
| CN107788436A (zh) * | 2016-09-01 | 2018-03-13 | 湖南益优生命科技有限公司 | 一种降脂减肥的组合物 |
-
2018
- 2018-10-08 CN CN201811165398.9A patent/CN109303115A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040037011A (ko) * | 2002-10-26 | 2004-05-04 | (주)바이오니아 | 유산균 함유 식품조성물 및 그 제조방법 |
| CN106912612A (zh) * | 2015-12-28 | 2017-07-04 | 中粮营养健康研究院有限公司 | 代餐奶昔粉及其制备方法 |
| CN107788436A (zh) * | 2016-09-01 | 2018-03-13 | 湖南益优生命科技有限公司 | 一种降脂减肥的组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 于鹰: "《养脾胃的黄金饮食》", 31 January 2015, 中国医药科技出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112690334A (zh) * | 2020-12-30 | 2021-04-23 | 菌联肽康(山东)医药有限公司 | 一种代餐减肥降三高奶昔代餐系列食品及其制备工艺 |
| CN116508993A (zh) * | 2023-03-21 | 2023-08-01 | 微康益生菌(苏州)股份有限公司 | 罗伊氏乳杆菌在制备具有代谢调节作用的益生菌剂中的应用 |
| CN116508993B (zh) * | 2023-03-21 | 2023-12-15 | 微康益生菌(苏州)股份有限公司 | 罗伊氏乳杆菌在制备具有代谢调节作用的益生菌剂中的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6869621B2 (en) | Diet composition comprising raw foods and dietary fibers | |
| CN107692240A (zh) | 一种高蛋白膳食组合物及其制备方法和应用 | |
| CN103653170B (zh) | 一种水苏糖益生菌固体饮料 | |
| CN108185288A (zh) | 一种全营养健胃代餐米稀及其制备方法和使用方法及用途 | |
| CN104643250B (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
| CN106261763A (zh) | 一种谷物膳食纤维代餐粉及其制备方法 | |
| CN105249452A (zh) | 一种具有减肥功能的果蔬酵素粉及其制备方法 | |
| CN106213495A (zh) | 减肥型代餐粉及其制备方法 | |
| CN103988863B (zh) | 一种具有保健功能的低热量、高营养烘焙食品 | |
| CN102813120B (zh) | 海参防癌降糖面粉及制备方法 | |
| CN105815514A (zh) | 藜麦减肥奶茶 | |
| CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
| CN103598333A (zh) | 一种健脾消食的酸奶及其加工工艺 | |
| CN109303115A (zh) | 生酮减肥代餐奶昔 | |
| CN105707378A (zh) | 黑青稞瘦身咖啡 | |
| CN102090453A (zh) | 瘦身美奶茶 | |
| CN105056005B (zh) | 一种能降脂减肥的药食同源组合物 | |
| CN103190677A (zh) | 一种谷物固体饮料及其制备工艺 | |
| CN109043259A (zh) | 一种酵素l-阿拉伯糖水苏糖复合饮料浓浆 | |
| CN115553406A (zh) | 抑制脂肪和糖类物质吸收的减肥组合物饮料及制备方法 | |
| CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 | |
| CN105995980B (zh) | 一种具有体重管理作用的组合物及其制备方法 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| CN1788578A (zh) | 一种微米松花魔芋露减肥降糖酸豆奶制备方法 | |
| CN104509915A (zh) | 一种番茄醋的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190205 |